These results show that our screen has uncovered evolutionarily conserved cancer genes that, collectively, correlate with the KRAS mutation status of tumors and predict survival of patients diagnosed with pancreatic cancer. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.